272 related articles for article (PubMed ID: 6467455)
1. The toxic effects in rats of some synthanecine carbamate and phosphate esters analogous to hepatotoxic pyrrolizidine alkaloids.
Driver HE; Mattocks AR
Chem Biol Interact; 1984 Sep; 51(2):201-18. PubMed ID: 6467455
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and toxicity of synthetic analogues of macrocyclic diester pyrrolizidine alkaloids.
Mattocks AR; Driver HE; Barbour RH; Robins DJ
Chem Biol Interact; 1986 Apr; 58(1):95-108. PubMed ID: 3708724
[TBL] [Abstract][Full Text] [Related]
3. Excretion of pyrrolic metabolites in the bile of rats given the pyrrolizidine alkaloid retrorsine or the bis-N-ethylcarbamate of synthanecine A.
White IN
Chem Biol Interact; 1977 Feb; 16(2):169-80. PubMed ID: 849622
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity.
Mattocks AR; Bird I
Chem Biol Interact; 1983 Feb; 43(2):209-22. PubMed ID: 6825198
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and toxicity of anacrotine, a pyrrolizidine alkaloid, in rats.
Mattocks AR; Driver HE
Chem Biol Interact; 1987; 63(1):91-104. PubMed ID: 3652286
[TBL] [Abstract][Full Text] [Related]
6. Hepato- and pneumotoxicity of pyrrolizidine alkaloids and derivatives in relation to molecular structure.
Culvenor CC; Edgar JA; Jago MV; Qutteridge A; Peterson JE; Smith LW
Chem Biol Interact; 1976 Mar; 12(3-4):299-324. PubMed ID: 1253333
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats.
Mattocks AR; Driver HE
Toxicology; 1983 Jun; 27(2):159-77. PubMed ID: 6612746
[TBL] [Abstract][Full Text] [Related]
8. Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids.
Mattocks AR
Chem Biol Interact; 1972 Sep; 5(4):227-42. PubMed ID: 5075756
[No Abstract] [Full Text] [Related]
9. Relation of structural features to pyrrolic metabolites in livers of rats given pyrrolizidine alkaloids and derivatives.
Mattocks AR
Chem Biol Interact; 1981 Jun; 35(3):301-10. PubMed ID: 7226276
[TBL] [Abstract][Full Text] [Related]
10. Detection of sulphur-conjugated pyrrolic metabolites in blood and fresh or fixed liver tissue from rats given a variety of toxic pyrrolizidine alkaloids.
Mattocks AR; Jukes R
Toxicol Lett; 1992 Oct; 63(1):47-55. PubMed ID: 1412522
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.
Ma J; Li M; Li N; Chan WY; Lin G
Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34679016
[TBL] [Abstract][Full Text] [Related]
12. Editor's Highlight: Identification of Any Structure-Specific Hepatotoxic Potential of Different Pyrrolizidine Alkaloids Using Random Forests and Artificial Neural Networks.
Schöning V; Hammann F; Peinl M; Drewe J
Toxicol Sci; 2017 Dec; 160(2):361-370. PubMed ID: 28973379
[TBL] [Abstract][Full Text] [Related]
13. Antimitotic activity of dehydroretronecine, a pyrrolizidine alkaloid metabolite, and some analogous compounds, in a rat liver parenchymal cell line.
Mattocks AR; Legg RF
Chem Biol Interact; 1980 Jun; 30(3):325-36. PubMed ID: 7379211
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of radioactivity in rats given tritiated analogues of hepatotoxic pyrrolizidine alkaloids.
Mattocks AR
Xenobiotica; 1977 Nov; 7(11):665-70. PubMed ID: 930115
[TBL] [Abstract][Full Text] [Related]
15. Evaluation in vitro of several pyrrolizidine alkaloid carcinogens: observations on the essential pyrrolic nucleus.
Styles J; Ashby J; Mattocks AR
Carcinogenesis; 1980 Feb; 1(2):161-4. PubMed ID: 22282996
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the chronic hepatotoxicity of pyrrolizidine alkaloids.
Jago MV
J Pathol; 1971 Sep; 105(1):1-11. PubMed ID: 5129752
[No Abstract] [Full Text] [Related]
17. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
Yan CC; Cooper RA; Huxtable RJ
Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
[TBL] [Abstract][Full Text] [Related]
18. The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity.
Lu Y; Ma J; Song Z; Ye Y; Fu PP; Lin G
Arch Toxicol; 2018 Nov; 92(11):3403-3414. PubMed ID: 30244272
[TBL] [Abstract][Full Text] [Related]
19. Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human.
Zhu L; Zhang C; Zhang W; Xia Q; Ma J; He X; He Y; Fu PP; Jia W; Zhuge Y; Lin G
Arch Toxicol; 2021 Oct; 95(10):3191-3204. PubMed ID: 34390356
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid.
Lin G; Cui YY; Hawes EM
Drug Metab Dispos; 2000 Dec; 28(12):1475-83. PubMed ID: 11095586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
